Quotient Sciences Header

Quotient Sciences Header

X

Find Clinical Drug Development Pipelines & Deals | PipelineProspector

Filters

×

FILTER:

filter

News Type

filter

Company

filter

Product Type

filter

Deal Size

filter

Upfront Payment

Active Filter(s):

Filters

Reset Filter

All Developments

Product Type

Companies

Sanofi

Contact Supplier

Pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.

Contact Supplier

Contact Supplier

Digital Content

New Dupixent® (Dupilumab) Data at ERS Adds to Body of Safety and Efficacy Data in Chronic Respiratory Diseases

Details:

Dupixent (dupilumab), is a fully human monoclonal antibody that inhibits the signaling of the interleukin-4 (IL-4) and interleukin-13 (IL-13) pathways and is not an immunosuppressant.

Lead Product(s): Dupilumab

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Dupixent

Highest Development Status: Approved Product Type: Large molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable August 30, 2022

Sanofi Company Banner

DDF Summit 2022 US

Not Confirmed

envelop

Contact Supplier

Dr. Reddy's Laboratories

Contact Supplier

Offering a portfolio of products & services including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Contact Supplier

$Dr. Reddy\'s Laboratories$

Digital Content

Dr. Reddy’s Announces the First-to-Market Launch of Over-the-Counter, Store-Brand Equivalent of Allegra-D® 24 Hr in the U.S. Market

Details:

Allegra-D (fexofenadine) is an over-the-counter oral antihistamine and nasal decongestant for the temporary relief of nasal and sinus congestion due to colds or allergies.

Lead Product(s): Fexofenadine Hydrochloride,Pseudoephedrine

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Allegra-D

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Not Applicable

Deal Size: Not Applicable Upfront Cash: Not Applicable

Deal Type: Not Applicable July 22, 2022

Dr Reddy Company Banner

CPhI Worldwide 2022

Booth # 80B60

envelop Contact Supplier

Dr. Reddy's Laboratories

Contact Supplier

Offering a portfolio of products & services including APIs, CMO services, generics, biosimilars & differentiated formulations.

Contact Supplier

Contact Supplier

$Dr. Reddy\'s Laboratories$

Digital Content

Mankind Pharma to Acquire Combihale and Daffy Brands From Dr Reddy's Laboratories

Details:

The acquisition of “Combihale” is expected to strengthen Mankind’s presence in the inhalation respiratory market segment. Daffy is a soap-free moisturising bar for infant babies.

Lead Product(s): Formoterol Fumarate,Fluticasone Propionate

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Combihale

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: Mankind Pharma

Deal Size: Undisclosed Upfront Cash: Undisclosed

Deal Type: Acquisition February 16, 2022

Dr Reddy Company Banner

CPhI Worldwide 2022

Booth # 80B60

envelop Contact Supplier

Vectura Ltd

Contact Supplier

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Contact Supplier

Contact Supplier

Digital Content

Vectura Highlights Update Made by Hikma on Launch of Generic Advair Diskus®

Details:

Hikma will immediately resume launch activities of its generic product for Advair Diskus® (Fluticasone Propionate and Salmeterol Inhalation Powder, USP), 100mcg/50mcg and 250mcg/50mcg doses in the US.

Lead Product(s): Fluticasone Propionate,Salmeterol Xinafoate

Therapeutic Area: Pulmonary/Respiratory Diseases Product Name: Fluticasone Propionate/Salmeterol-Generic

Highest Development Status: Approved Product Type: Small molecule

Partner/Sponsor/Collaborator: